SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SK Biopharmaceuticals Co Ltd
Research & Development Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-â‚©134.2B
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Research & Development
-â‚©146.9B
CAGR 3-Years
0%
CAGR 5-Years
-11%
CAGR 10-Years
-16%
Hanmi Science Co Ltd
KRX:008930
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-â‚©186B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-â‚©5.9B
CAGR 3-Years
40%
CAGR 5-Years
12%
CAGR 10-Years
-14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Research & Development
-â‚©14.8B
CAGR 3-Years
-37%
CAGR 5-Years
-51%
CAGR 10-Years
-23%

See Also

What is SK Biopharmaceuticals Co Ltd's Research & Development?
Research & Development
-134.2B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Research & Development amounts to -134.2B KRW.

What is SK Biopharmaceuticals Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-2%

Over the last year, the Research & Development growth was -11%. The average annual Research & Development growth rates for SK Biopharmaceuticals Co Ltd have been -7% over the past three years , -2% over the past five years .

Back to Top